EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

The Outcome of Tuberculosis Treatment in the Presence of SARS-CoV-2 Anti-RBD Antibody

Heni Muflihah iD, Fajar Awalia Yulianto iD, Winni Maharani iD, Anis Rapiq Hanipan

Infection and Drug Resistance · 2026-07 · Volume 19 · 1-9

DOI: 10.2147/idr.s579272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Drug Resistance, 2026-07. Verfasst von Heni Muflihah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, Universitas Islam Bandung, Bandung, Indonesia. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

COVID-19SARS-CoV-2 antibodyanti-RBD antibodyinterferon gammatreatmenttuberculosis

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Medicine, Universitas Islam Bandung, Bandung, Indonesia.
  • Immunoserology and Cell Culture, Research Laboratory, Faculty of Medicine Universitas Islam Bandung, Bandung, Indonesia.
  • Department of Public Health, Faculty of Medicine, Universitas Islam Bandung, Bandung, Indonesia.
  • Department of Microbiology, Faculty of Medicine, Universitas Islam Bandung, Bandung, Indonesia.

ORCID-Profile: Heni Muflihah, Fajar Awalia Yulianto, Winni Maharani

Zitieren

APA

Muflihah, H., Yulianto, F. A., Maharani, W., & Hanipan, A. R. (2026). The Outcome of Tuberculosis Treatment in the Presence of SARS-CoV-2 Anti-RBD Antibody. Infection and Drug Resistance, Volume 19, 1-9. https://doi.org/10.2147/idr.s579272

Vancouver

Muflihah H, Yulianto FA, Maharani W, Hanipan AR. The Outcome of Tuberculosis Treatment in the Presence of SARS-CoV-2 Anti-RBD Antibody. Infection and Drug Resistance. 2026;Volume 19:1-9. doi:10.2147/idr.s579272

BibTeX
@article{Muflihah2026,
  author = {Muflihah, Heni and Yulianto, Fajar Awalia and Maharani, Winni and Hanipan, Anis Rapiq},
  title = {The Outcome of Tuberculosis Treatment in the Presence of SARS-CoV-2 Anti-RBD Antibody},
  journal = {Infection and Drug Resistance},
  year = {2026},
  volume = {Volume 19},
  pages = {1--9},
  doi = {10.2147/idr.s579272}
}
Kostenlos starten →